Introduction {#S1}
============

Since the discovery of 2-methylisoborneol (2-MIB, **1**) by Gerber in 1969, there has been considerable interest in the detection, bioremediation, and biosynthesis of this volatile, odiferous homo-monoterpene ([Figure 1](#F1){ref-type="fig"}).^[@R1]--[@R4]^ Possessing a musty odor and muddy off-taste, as well as an extremely low threshold of detection by humans (\<10 ng/L), 2-MIB is produced by a wide range of Gram-positive actinomycetes, myxobacteria, and cyanobacteria, being second in occurrence only to the common odoriferous sesquiterpene geosmin.^[@R5]^

The elucidation of the biosynthesis of 2-methylisoborneol at the molecular genetic and biochemical level was independently reported in 2008 by two research groups ([Figure 1](#F1){ref-type="fig"}).^[@R6]--[@R8]^ The 2-MIB biosynthetic gene cluster in *Streptomyces coelicolor* was shown to harbor a terpene synthase gene (*sco7700*) translationally coupled to the gene for an *S*-adenosyl-L-methionine (SAM)-dependent C-methyl transferase, (*sco7701*), as well as a third gene (*sco7699*) encoding a protein of still unknown function, annotated only as a nucleotide-binding protein.^[@R7]^ This three-gene biosynthetic operon is highly conserved across the genome sequences of more than three dozen bacterial species.^[@R3],[@R5],[@R6]^ The SAM-dependent geranyl diphosphate C-methyltransferase (GPPMT) (Sco7701) was shown to catalyze the first step in the biosynthetic pathway in *S. coelicolor*, the electrophilic methylation of the olefinic C-2 position of geranyl diphosphate (GPP, **2**) to form (*E*)-2-methylgeranyl diphosphate (2-MeGPP, **3**).^[@R7]^ Sco7700, 2-methylisoborneol synthase (MIBS), catalyzes the Mg^2+^-dependent multistep cyclization of the acyclic 2-MeGPP precursor to the bicyclic alcohol 2-MIB (**1**) which is accompanied by small amounts of the bicyclic homo-monoterpenes 2-methylenebornane (**4**), 2-methylbornene (**5**), and 1-methylcamphene (**6**), The only other enzyme known to utilize 2-MeGPP as substrate is the closely related 2-methylenebornane synthase (Pfl_1841) of *Pseudomodas fluorescens* PfO-1.^[@R9]^ These findings were fully consistent with the results of independent whole-cell precursor incorporation experiments involving the feeding of \[*methyl*-^13^C\]methionine and samples of deuterated mevalonate to the myxobacterium *Nannocycstis exedens* and MS analysis of the resulting 2-methylisoborneol in the head space volatiles.^[@R4]^

The proposed 2-methylisoborneol synthase mechanism is based on close analogy to the well-documented cyclization mechanisms established for a wide range of monoterpene synthases ([Figure 2](#F2){ref-type="fig"}).^[@R10]^ MIBS initiates the electrophilic cyclization by ionizing the Mg^2+^-complexed substrate 2-MeGPP (**3**) to generate the corresponding allylic cation--pyrophosphate ion pair which then collapses to the *transoid* conformer of the allylic isomer (3*R*)-2-methyllinalyl diphosphate (2-MeLPP, **7**). Rotation about the C-2,3-bond generates the *cisoid* conformer of **7**, folded in the *anti-endo-*boat conformation, which then undergoes ionization and cyclization to generate the (4*R*)-2-methyl-α-terpinyl cation (**8**). Electrophilic attack on the cyclohexenyl double bond of **8** generates the 2-methyl-2-bornyl cation (**9**), which is then quenched on the *exo* face by bound water to generate 2-methylisoborneol (**1**). Competing deprotonation of intermediate **9** or its proximal rearrangement product readily accounts for formation of the co-products **4**, **5**, and **6**. The MIBS cyclization mechanism, including the deduced stereochemistry and conformations of the various intermediates, closely resembles that firmly established for (+)-bornyl diphosphate synthase/α-pinene synthase (BPPS) from *Salvia officinalis* which converts geranyl diphosphate (GPP, **2**) to (+)-bornyl diphosphate ((+)-BPP) (75 %) as well as a mixture of the monoterpene hydrocarbons (+)-α-pinene, (+)-camphene, (±)-limonene and terpinolene (25% total olefins) ([Figure 3](#F3){ref-type="fig"}).^[@R11]--[@R13]^ There are of course two key differences between the reactions catalyzed by MIBS and by BPPS: 1) MIBS cyclizes 2-MeGPP instead of GPP. Although MIBS can cyclize GPP to a mixture of monocyclic and bicyclic monoterpenes, the observed *k*~cat~ is four orders of magnitude lower than that for the natural methylated substrate 2-MeGPP.^[@R7]^ 2) The final step in the MIBS-catalyzed cyclization cascade is the quenching of the 2-methyl-2-bornyl cation exclusively on the *exo* face by a bound water ([Figure 2](#F2){ref-type="fig"}), while in the BPPS-catalyzed reaction, the paired pyrophosphate ion is recombined with the bornyl cation exclusively by *endo* attack ([Figure 3](#F3){ref-type="fig"}).

High resolution crystal structures have recently been determined for MIBS in both an unliganded state and in complex with a number of substrate or intermediate analogues.^[@R14],[@R15]^ The 1.80 -- 1.95 Å structures of MIBS bound to geranyl-*S*-thiolodiphosphate and 2-fluorogeranyl diphosphate, respectively, show each analogue coordinated with two 2 Mg^2+^ ions and bound in extended conformations in which the 6,7-double bond of each analogue is twisted away from the parallel relationship expected for the postulated *anti-endo-*boat conformation of the actual cyclizing *cisoid* (3*R*)-2-MeLPP intermediate ([Figure 2](#F2){ref-type="fig"}).^[@R14]^ Although this deviation may simply be the result of crystallographic trapping of a thermodynamically stable, rather than a kinetically or mechanistically relevant conformer, more interestingly it reflects the fact that the required 180° rotation of the 2-propenyl substituent about the C-2,3 bond of the *anti-endo-*boat conformer of the (3*R*)-2-methyl linalyl diphosphate intermediate is sterically forbidden by a clash with the 6,7-double bond that is augmented by the presence of the C2-methyl substituent. It is thus probable that adoption of the *endo-boat* conformation takes place *subsequent to* conversion of the *transoid* to the *cisoid* conformer of 2-MeLPP. Such extended 6,7-double bond conformations of bound substrate analogues have previously been observed in the structures of a number of canonical monoterpene synthases.^[@R16],[@R17]^ Also thought-provoking were the unexpected results from co-crystallization of MIBS with racemic 2-fluorolinalyl diphosphate (2-FLPP), which had been predicted to be an unreactive analogue of the natural (3*R*)-2-methyllinalyl diphosphate intermediate due to the strongly electron-withdrawing 2-fluoro substituent. The 2.00 Å structure of the resulting complex revealed that the MIBS-bound 2-FLPP had undergone a reverse allylic rearrangement to generate bound 2-fluoroneryl diphosphate in complex with 2 Mg^2+^ ions.^[@R15]^ Also unexpectedly, it was found that in solution MIBS converted the supposedly unreactive 2-FLPP to camphor, no doubt formed by cyclization of 2-FLPP and spontaneous elimination of HF from enzymatically-generated 2-fluoro-2-isoborneol. The observation of enzyme-generated 2-fluoroneryl diphosphate trapped within the active site of MIBS raises the question whether the *cis* geometric isomer of 2-FGPP is a true intermediate of the MIBS-catalyzed ionization and cyclization of 2-FLPP, the nominally unreactive analogue of the natural intermediate 2-MeLPP (**7**), or merely an anomalous shunt metabolite of the reverse allylic diphosphate rearrangement. We have therefore now examined the incubation of MIBS with 2-methylneryl diphosphate (2-MeNPP, **10**), the *cis* isomer of the natural substrate, 2-methylgeranyl diphosphate (2-MeGPP, **3**), and report the results below.

Results {#S2}
=======

Preparation of 2-methylneryl diphosphate (10) and (±)-2-methyl-α-terpineol (13) {#S3}
-------------------------------------------------------------------------------

To prepare 2-methylneryl diphosphate (**11**, 2-MeNPP), we used a modification of the previously reported synthesis of the *trans* isomer 2-methylgeranyl diphosphate (**3**, 2-MeGPP) ([Figure 4](#F4){ref-type="fig"}).^[@R7]^ Wadsworth-Horner-Emmons reaction of 6-methyl-5-hepten-2-one with triethyl 2-phosphonopropionate followed by LiAlH~4~ reduction of the resulting mixture of *Z* and *E* conjugated esters gave a 1:1 mixture of (*Z*)-2-methylnerol (**11**) and (*E*)-2-methylgeraniol (**12**) which were cleanly resolved by flash column chromatography (see SI for details). The purified 2-methylnerol (**11**) was reacted with triphenylphosphine and CCl~4~ in an Appel reaction and the resulting 2-methylneryl chloride was then directly reacted without further purification with tris(tetrabutylammonium) hydrogen pyrophosphate to give 2-methylneryl diphosphate (**10**, 2-MeNPP). The corresponding \[1-^3^H\]-2-methylneryl diphosphate (\[1-^3^H\]-**10**, \[1-^3^H\]-2-MeNPP) was similarly prepared by oxidation of the mixture of 2-methylnerol and 2-methylgeraniol to the derived mixture of aldehydes, followed by reduction with NaBH~3~T and chromatographic separation of the resulting mixture of \[1-^3^H\]-2-methylnerol and \[1-^3^H\]-2-methylgeraniol using AgNO~3~-impregnated silica gel.

For the planned enzyme incubations, we also needed an authentic reference sample of the homo-monoterpene alcohol (±)-2-methyl-α-terpineol (**13**),^[@R18]^ which was readily prepared by biomimetically-modeled, *p*-TsOH-catalyzed solvolysis of 2-methylnerol (**11**) in nitromethane ([Figure 4](#F4){ref-type="fig"}).

*In vitro* incubation of 2-methylneryl diphosphate with 2-methylisoborneol synthase {#S4}
-----------------------------------------------------------------------------------

Before examining the cyclization of 2-methylneryl diphosphate by methylisoborneol synthase, we carried out individual control incubations in the absence of enzyme with 2-MeGPP and 2-MeNPP and analyzed the pentane-soluble extracts by chiral GC-MS in order to identify and quantify the formation of Mg^2+^-catalyzed solvolysis products ([Figures 5a and 5b](#F5){ref-type="fig"}). The control incubation with 2-MeGPP produced only racemic (±)-2-methyllinalool (**14**). The exclusive formation of this tertiary allylic alcohol contrasts with the well-known Mg^2+^-catalyzed solvolysis of GPP itself, which typically gives a 3:1 mixture of linalool and geraniol.^[@R18]^ The preferred formation of 2-methyllinalool (**14**) by solvolysis of 2-MeGPP presumably reflects the higher free energy of 2-methylgeraniol due to the increased steric hindrance about the tetra-substituted double bond compared to geraniol. By contrast, the control Mg^2+^-catalyzed solvolysis of 2-MeNPP gave a mixture of three racemic products, consisting of acyclic (±)-2-methyllinalool (**14**) as well as the monocyclic (±)-2-methyllimonene (**15**), and (±)-2-methyl-α-terpineol (**13**) ([Figure 5b](#F5){ref-type="fig"}). The Mg^2+^-catalyzed formation of both (±)-**13** and (±)-**15** from 2-MeNPP, but not from 2-MeGPP, is consistent with the fact that the (*E*)-allylic diphosphate 2-MeGPP (**3**) is geometrically incapable of direct cyclization. As a positive control, incubation of 2-MeGPP (**3**) with 2-methylisoborneol synthase and chiral GC-MS analysis confirmed the formation of (−)-2-methyisoborneol (2-MIB, **1**) as the major product (89 %) accompanied by minor amounts of enantiomerically pure 2-methylenebornane (**4**) (10 %), 1-methylcamphene (**6**) (\<1 %) and 2-methyl-2-bornene (**5**) (\<1 %), as previously observed ([Figure 5c](#F5){ref-type="fig"} and [Table 1](#T1){ref-type="table"}).^[@R6],[@R7]^

Incubation of 2-MeNPP (**10**) with MIBS and analysis by chiral GC-MS revealed the production of the same group of homochiral bicyclic homo-monoterpenes, (−)-2-methylisoborneol (**1**, 17%), 2-methylenebornane (**13**, 26%), 1-methylcamphene (**6**) (\<1 %) and 2-methyl-2-bornene (**5**) (\<1 %), but in both substantially different proportions and lower overall yield compared to 2-MeGPP ([Figures 5d](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Significantly, four additional, previously unobserved products constituting \>56% of the overall mixture were formed: monocyclic 2-methyllimonene (**15**, 39 %) and 2-methyl-α-terpineol (**13**, 10 %) along with the acyclic alcohols 2-methylnerol (**11**, 7%) and 2-methyllinalool (**14**, \<1%) ([Table 1](#T1){ref-type="table"}, [Figures 5d](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Interestingly, correction for background Mg^2+^-catalyzed solvolysis of the 2-MeNPP substrate revealed that both 2-methyl-α-terpineol (**13**) and 2-methyllinalool (**14**) were formed as single enantiomers, while 2-methyllimonene (**15**) was generated as a racemic mixture. The absolute configurations of the enzymatically-generated products **13** and **14** were not determined.

Steady-state kinetics {#S5}
---------------------

The steady-state kinetic parameters for the MIBS-catalyzed conversion of \[1-^3^H\]-2-MeNPP (**10**) to total pentane soluble homo-monoterpene products were determined and directly compared with those re-determined for the natural substrate \[1-^3^H\]-2-MeGPP (**3**) under identical conditions ([Table 2](#T2){ref-type="table"}). While the turnover number, *k*~cat~, for 2-MeNPP (0.0045 s^−1^) was \~20-fold lower than that for 2-MeGPP, the observed *k*~cat~/*K*~m~, of 255 M^−1^s^−1^ for 2-MeNPP was only 4-fold lower than that for 2-MeGPP (1105 M^−1^s^−1^), reflecting a partially compensating \~5-fold decrease in the observed *K*~m~ for 2-MeNPP compared to 2-MeGPP.^[@R8]^

Discussion {#S6}
==========

Although (*Z*)-2-methylneryl diphosphate (**10**, 2-MeNPP) shows only a modest 4-fold decrease in the specificity constant *k*~cat~/*K*~m~ compared to the natural substrate, the *trans* geometric isomer (*E*)-2-methylgeranyl diphosphate (**3**, 2-MeGPP), the substantially altered product distributions resulting from incubation of 2-MeNPP with 2-methylisoborneol synthase establish that 2-MeNPP is a poor surrogate for 2-MeGPP. Thus, while 2-MeNPP could, in principle, be ionized to the same *cisoid* allylic cation -- pyrophosphate ion pair as the presumptive intermediate (3*R*)-2-methyllinalyl diphosphate (**7**, 2-MeLPP), in practice incubation of 2-MeNPP with 2-methylisoborneol synthase generated a substantially altered array of bicyclic and monocylic homo-monoterpene products. Thus, although cyclization of 2-MeNPP generated only a single enantiomer of each of the four natural bicyclic natural products, 2-methylisoborneol (**1**), 2-methylenebornane (**4**), 2-methylbornene (**5**), and 1-methylcamphene (**6**), the relative proportion of **1** was reduced more than 5-fold from 89% to 17% of the total product mixture, only partially offset by an increase in the fraction of 2-methylenebornane (**4**) which increased from 10% to 26% ([Table 1](#T1){ref-type="table"}). The majority of the product mixture resulting from the MIBS-catalyzed cyclization of 2-MeNPP (**10**) consisted of the anomalous monocyclic homo-monoterpenes (±)-2-methyllimonene (**15**, 39%) and a single enantiomer of 2-methyl-α-terpineol (**13**, 10%), as well as the acylic derivatives 2-methylnerol (**11**, 7%) and a single enantiomer of 2-methyllinalool (**14**, \<1%). Interestingly, while **13**, **14**, and **15** are not detected among the products of the *in vitro* incubation of 2-methylisoborneol synthase with 2-MeGPP, all three of these homo-monoterpenes, of unspecified chiral purity, have been reported as minor components of the volatile headspace extracts of a small number of 2-methylisoborneol-producing actinomycetes.^[@R19],[@R20]^

Substantial changes in product distribution have been reported when the *cis* isomer neryl diphosphate is incubated with monoterpene synthases in place of the natural *trans* allylic substrate, geranyl diphosphate. For example, in spite of only minor differences in overall *k*~cat~, incubation (+)-BPP/(+)-pinene synthase with NPP instead of GPP resulted in a decrease in the proportion of the bicyclic monoterpenes α-pinene and camphene from 79% to 23%, while the fraction of the monocyclic products limonene and α-terpinolene exhibited a substantial increase from 15% to 71% of total monoterpenes.^[@R21]^ The enhanced formation of abortive cyclization products is almost certainly the consequence of aberrant positioning of 2-MeNPP and NPP in the active sites of the respective homo-monoterpene or monoterpene synthases, compared to the binding of the native substrates 2-MeGPP or GPP.

The fact that cyclization of 2-MeNPP by 2-methylisoborneol synthase generates the naturally occurring enantiomers of 2-methylisoborneol (**1**), 2-methylenebornane (**4**), 2-methylbornene (**5**), and 1-methylcamphene (**6**) indicates that at least a portion of this anomalous substrate is bound to MIBS in a position and conformation that is compatible with, but certainly not identical to, the precise folding of the natural substrate 2-MeGPP (**3**) and the derived intermediate (3*R*)-2-MeLPP (**7**) in the MIBS active site. Although the 2-methylllimonene (**15**) and 2-methyl-α-terpineol (**13**) formed from 2-MeNPP are both formally derivable from a common 2-methyl-α-terpinyl cation, the fact that **15** is generated as a racemic mixture while **13** is produced as a single enantiomer indicates clearly that they cannot both be derived from a single monocyclic carbocation intermediate. The surrogate 2-MeNPP substrate therefore must be bound in at least two distinct conformations during MIBS catalyzed cyclization. The fact that only a single enantiomer of each of bicyclic, monocyclic, and acyclic alcohols **1**, **13**, and **14** is produced by incubation of 2-MeNPP with MIBS also suggests that the same bound water molecule is responsible for quenching the corresponding carbocation intermediates.

Experimental Section {#S7}
====================

Materials {#S8}
---------

Reagents and solvents were purchased from Sigma-Aldrich or Fisher Scientific, were of the highest quality available, and were used without further purification. NaBH~3~T solution (6 μmol, 80 Ci/mmol specific activity, 500 mCi total in 1 mL of 0.01 N NaOH) was purchased from American Radiolabeled Chemicals. Isopropylthio-D-galactopyranoside (IPTG) was purchased from Invitrogen. Ni-NTA affinity resin was from Qiagen. Amicon Ultra Centrifugal Filter Units (Amicon Ultra-15 10,000 MWCO) were purchased from Millipore. Purified SCO7700 protein was overexpressed and purified as previously described.^[@R7]^

Methods {#S9}
-------

Gas chromatography--mass spectrometry (GC--MS) analyses were performed using an Agilent 5977A Series GC/MSD instrument (70 eV, electron impact), a 1-μL injection volume, and a 3 min solvent delay. Achiral GC--MS conditions used an HP-5ms capillary column (0.25 mm ID × 30 m length × 0.25 μm film, Agilent Technologies) and a temperature program with a 2 min hold at 60 °C, a 20 °C min^−1^ increment to 280 °C, followed by a 2 min hold at 280 °C. Chiral GC--MS separations were preformed using a CP-ChiralSil-Dex column (0.32 mm ID × 25 m length × 0.25 μm film, Agilent) and a temperature program with a 1 min hold at 50 °C, a 10 °C min^−1^ increment to 200 °C, followed by a 1 min hold at 200 °C. Compounds detected by GC--MS were directly compared to their authentic standards using the MassFinder 4.2.1 program (<http://www.massfinder.com>). Retention indices were measured using C~8~--C~20~ and C~10~--C~40~ alkane standards.

Liquid chromatography-mass spectrometry (LC-MS) analyses were performed using a Finnigan LXQ LC-MS instrument in negative ESI mode, with a Waters Symmetry C~18~ column (35 μM, 2.1 × 50 mm), a 10 μL injection volume and 1 min signal delay. The method used was a 1 min isocratic gradient of 95:5 water:acetonitrile, a gradient to 5:95 water:acetonitrile over 5 min, followed by isocratic elution with 5:95 water:acetonitrile for 9 min. NMR spectra were obtained using a Bruker Avance AV400 NMR spectrometer operating at a 400 MHz ^1^H frequency or a Bruker Avance AV300 NMR spectrometer operating at a 300 MHz ^1^H frequency. Liquid scintillation counting was performed using a Beckman-Coulter LS6500 scintillation counter and Opti-Flour scintillation cocktail from Perkin-Elmer.

All proteins were handled at 4 °C unless otherwise stated. Protein concentrations were determined according to the method of Bradford with bovine serum albumin as the standard.^[@R22]^ Protein purity was estimated using SDS PAGE gel electrophoresis and visualized using Coomassie Blue stain according to the method of Laemmli.^[@R23]^

2-methylneryl diphosphate (10) {#S10}
------------------------------

The *cis* isomer 2-methylnerol (**11**) was obtained by preparation of a 1:1 mixture of 2-methylnerol (**11**) to 2-methylgeraniol (**12**) and separation of the isomeric alcohols using column chromatography as previously described.^[@R7]^ The purified 2-methylnerol was then converted to 2-methylneryl diphosphate (**10**), using the method developed by Poulter.^[@R24]^ Triphenylphosphine (1.27 g, 4.75 mmol) was added to a stirring solution of 2-methylnerol (**11**) (200 mg, 1.19 mmol) in anhydrous CCl~4~ (16 mL) and the mixture was refluxed for 24 h. The solvent was evaporated *in vacuo* and the resulting slurry was triturated with pentane (30 mL) and filtered by suction filtration. Concentration of the pentane filtrate at room temperature provided crude 2-methylneryl chloride, which was used in the subsequent reaction without further purification. Tris(tetrabutylammonium) hydrogen pyrophosphate (1.58 g, 2.38 mmol) was added to the 2-methylneryl chloride in dry CH~3~CN (10 mL) under nitrogen and the reaction was stirred at room temperature for 2 days. The solvent was removed under a gentle stream of N~2~ to give a viscous, light brown liquid, followed by the addition of 30 mL of 0.05 M KHCO~3~ and extraction with ether (5 × 5 mL) to remove organic impurities. The resulting aqueous phase was applied to a DEAE-Sephadex column that had been equilibrated with 0.05 M KHCO~3~. After loading, the column was washed with 100 mL of 0.05 M KHCO~3~ and eluted with a linear gradient of 0.05 M KHCO~3~ (300 mL) to 1.0 M KHCO~3~ (300 mL) at a flow rate of 2.0 mL/min. Fractions (35 mL) were collected and lyophilized and those containing 2-methylneryl diphosphate (**10**) were dissolved in a minimum amount of dH~2~O and applied to a CHP-20P column equilibrated with dH~2~O. The column was run with a stepwise gradient of 100 mL of dH~2~O, 100 mL of 5% aqueous CH~3~CN, 100 mL of 10% aqueous CH~3~CN, 100 mL of 20 % aqueous CH~3~CN in H~2~O and 100 mL of 60 % aqueous CH~3~CN in H~2~O. Fractions were lyophilized to yield 105 mg of 2-methylneryl diphosphate (**10**) as a pale yellow solid (27 % yield). R*~f~* = 0.35 (6:3:1 propanol to NH~4~OH to water). ^1^H NMR (400 MHz, D~2~O) δ 5.08 (t, *J* = 4.5 Hz, 1H, H-6), 4.31 (d, *J* = 4.0 Hz, 2H, H-1), 2.05 (m, 2H, H-4), 1.98 (m, 2H, H-5), 1.61 (s, 3H, H-11), 1.58 (s, 3H, H-9), 1.55 (s, 3H, H-10), 1.49 (s, 3H, H-8). ^31^P {^1^H} NMR (161 MHz, D~2~O) δ −6.6 (d, *J* = 22.5 Hz, P~β~), −10.4 (d, *J* = 22.5 Hz, P~α~). ^13^C {^1^H} NMR (75 MHz, D~2~O): δ 16.1 (CH~3~), 17.0 (CH~3~), 18.2 (CH~3~), 24.9 (CH~3~), 26.6 (CH~2~), 33.3 (CH~2~), 66.3 (CH~2~), 124.1 (CH), 133.8 (C), 135.6 (C), 160.3 (C). LC-MS (neg ion ESIMS) *m/z* 326.99.

\[1-^3^H\]-2-Methylneryl diphosphate (\[1-^3^H\]-10) and \[1-^3^H\]-2-methylgeranyl diphosphate (\[1-^3^H\]-3) {#S11}
--------------------------------------------------------------------------------------------------------------

A 1.0 mL solution of NaBH~3~T (6 μmol, 80 Ci/mmol, 500 mCi in 1 mL of 0.01 N NaOH) was added to a round bottom flask. The reagent vial was rinsed with 4 × 1 mL of 0.01 N NaOH which was added to the solution and then placed under argon, cooled in an ice bath. An ice-cold 1:1 mixture of 2-methylneral to 2-methylgeranial (425 mg, 2.55 mmol), freshly prepared as previously described,^[@R7]^ in dry EtOH (7.5 mL) was added slowly over 10 min. The reaction was stirred at 0 °C for 3 h, and the remaining aldehydes were reduced by the slow addition of unlabeled NaBH~4~ powder (75 mg, 2.0 mmol). The resulting solution was warmed to room temperature and stirred overnight. After a total of 22 h, the reaction was quenched by careful transfer of the mixture into ice-cold half-saturated aqueous NH~4~Cl (10 mL). The aqueous layer was extracted with Et~2~O (5 × 10 mL) and the combined extracts were dried, filtered, and concentrated to give 310 mg of yellowish liquid (72% crude chemical yield, 375 mCi, 75 % radiochemical yield). The residue was purified by flash chromatography on 10 % (w/w) AgNO~3~-impregnated silica gel \[EtOAc/hexanes (1:9); 4 × 16-cm column\] giving 100 mg of \[1-^3^H\]-2-methylnerol (\[1-^3^H\]-**11**, 25 % chemical yield, 128 mCi, 26 % radiochemical yield) and 210 mg of \[1-^3^H\]-2-methylgeraniol (\[1-^3^H\]-**12**, 48 % chemical yield, 247 mCi, 49 % radiochemical yield). The purified \[1-^3^H\]-2-methylnerol (\[1-^3^H\]-**11**) and \[1-^3^H\] 2-methylgeraniol (\[1-^3^H\]-**12**) were individually converted to the corresponding diphosphate esters using the same method employed for the synthesis of unlabeled **10** and **3** to yield 98 mg of \[1-^3^H\]-2-methylneryl diphosphate (\[1-^3^H\]-**10**), 37 % chemical yield, 6.2 mCi total radioactivity, 2.2 % radiochemical yield, 28 mCi/mmol specific activity) and 200.1 mg of \[1-^3^H\]2-methylgeranyl diphosphate (\[1-^3^H\]-**3**, 36 % chemical yield, 105 mCi total radioactivity, 36 % radiochemical yield, 232.8 mCi/mmol specific activity). The NMR spectra of (\[1-^3^H\]-**10** and of \[1-^3^H\]-**3** matched those of unlabeled **10** and **3**.^[@R7]^

2-Methyl-α-terpineol (13) {#S12}
-------------------------

*p-*TsOH (40 mg, 0.20 mmol) was added to a solution of 2-methylnerol (200 mg, 1.19 mmol) in 10 mL of MeNO~2~. The reaction mixture was stirred at rt for 1 h and monitored by TLC (5:1 hexanes/ethyl acetate). The crude product was concentrated *in vacuo* and purified by column chromatography (5:1 hexanes/ethyl acetate) yielding 44 mg of 2-methyl-α-terpineol (**13**, 22% yield). The NMR data matched those previously reported for **13** prepared by an alternative method.^19\ 1^H NMR (400 MHz, CDCl~3~) δ 1.98, (m, 2H, H-6), 1.85 (m, 2H, H-3), 1.72 (m, 1H, H-5), 1.65 (s, 6H, H-10, 11), 1.48 (m, 2H, H-4), 1.22 (s, 6H, H-8, 9). ^13^C {^1^H} NMR (100 MHz, CDCl~3~) δ 19.4 (C-9, CH~3~), 19.5 (C-8, CH~3~), 24.3 (C-3, CH~2~), 26.3 (C-6, CH~2~), 27.3 (C-4, CH~2~), 32.7 (C-11, CH~3~), 33.2 (C-10, CH~3~), 45.8 (C-5, CH), 72.9 (C-7, C), 125.0 (C-2, C), 125.8 (C-1, C). GC-MS (EI) *m*/*z* 168.1.

Incubations with 2-methylisoborneol synthase (SCO7700) {#S13}
------------------------------------------------------

Purified 2-methylisoborneol synthase (SCO7700) (10 μM) was added to a glass test tube containing 3.0 mL of assay buffer (50 mM PIPES, 100 mM NaCl, 15 mM MgCl~2~, 5 mM β-mercaptoethanol and 20 % glycerol, pH 6.7) and 60 μM of either 2-methylneryl diphosphate (**10**) or 2-methylgeranyl diphosphate (**3**). The enzymatic reaction mixture was overlaid with 3.0 mL of pentane and incubated at 30 °C for 2 h. The enzymatic products were extracted with 3 × 3.0 mL of pentane and the organic extracts dried over Na~2~SO~4~, filtered, concentrated *in vacuo* to 100 μL and analyzed by GC-MS. Control reactions, measuring the background Mg^2+^-catalyzed hydrolysis of each substrate, were conducted similarly as above minus the addition of SCO7700 to the incubation mixture. An internal geraniol standard (25 pmoles) was added to the organic extracts of the enzymatic and control incubations after extraction.

Steady-state kinetics {#S14}
---------------------

Kinetic analyses were performed in 1 mL of assay buffer (50 mM PIPES, 15 mM MgCl~2~, 100 mM NaCl, 5 mM β-mercaptoethanol, 20 % glycerol, pH 6.7) with either 2-methylneryl diphosphate (**10**, 10 -- 500 μM) and \[1-^3^H\]-2-methylneryl diphosphate (\[1-^3^H\]-**10**, 8.4 Ci/mol) or 2-methylgeranyl diphosphate (**3**, 10 -- 500 mM) and \[1-^3^H\]2-methylgeranyl diphosphate ((\[1-^3^H\]-**3**, 16.5 Ci/mol). The reactions were initiated by the addition of 0.20 μM of SCO7700 protein, overlaid with 1 mL of pentane and incubated at 30 °C for 17 min. The reactions were quenched by the addition of 75 μL of 500 mM EDTA (pH 8.0) and vortexing for 30 s. The pentane layer was loaded onto a silica column (2 cm) in a Pasteur pipette and forced through with a stream of nitrogen into a scintillation vial containing 7 mL of Opti-Fluor. The enzymatic reaction mixture was extracted 3 more times with 1 mL of ether, and all organic extracts were passed through the silica column and collected. The combined extracts were assayed by liquid scintillation counting using a Beckman-Coulter LS6500 scintillation counter. Kinetic constants were calculated using the program Kaleidagraph 4.0 and were fit to the Michaelis-Menten equation. Reported standard deviations in the steady-state kinetic parameters represent the calculated statistical errors in the nonlinear, least squares regression analysis.
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![Biosynthesis of 2-methylisoborneol (**1**).](nihms848105f1){#F1}

![Mechanism of the MIBS-catalyzed cyclization of 2-methylgeranyldiphosphate (**3**) to 2-methylisoborneol (**1**).](nihms848105f2){#F2}

![Mechanism of bornyl diphosphate/α-pinene synthase.](nihms848105f3){#F3}

![Synthesis of 2-methylneryl diphosphate (**10**, 2-MeNPP) and 2-methyl-α-terpineol (**13**).](nihms848105f4){#F4}

![Chiral GC-MS analysis (TIC) of incubations with methylisoborneol synthase (MIBS). a) Control incubation of 2-MeGPP (**3**) in Mg^2+^-containing buffer without MIBS. b) Control incubation of 2-MeNPP (**10**) in Mg^2+^-containing buffer without MIBS. c) Incubation of MIBS with 2-MeGPP (**3**). d) Incubation of MIBS with 2-MeNPP (**10**). Previously unobserved product peaks are shown in red. Peaks denoted with \* are geraniol internal standard.](nihms848105f5){#F5}

![Mechanism of the MIBS-catalyzed transformation of 2-MeNPP (**10**).](nihms848105f6){#F6}

###### 

Distribution of products from the incubation of 2-MeGPP (**3**) and 2-MeNPP (**10**) with 2-methylisoborneol synthase.

                     Product (%)                                                                                                                                                                              
  ------------------ ------------- ---- ----- ----- ------------------------------------------------------------------------- -------------------------------------------------------------------------- ---- ---------------------------------------------------------------------------
  2-MeGPP (**3**)    89            10   \<1   \<1   ND[a](#TFN1){ref-type="table-fn"}                                         ND                                                                         ND   ND
  2-MeNPP (**10**)   17            26   \<1   \<1   10[b](#TFN2){ref-type="table-fn"} (10/0)[c](#TFN3){ref-type="table-fn"}   39[b](#TFN2){ref-type="table-fn"} (17/22)[c](#TFN3){ref-type="table-fn"}   7    \<1[b](#TFN2){ref-type="table-fn"} (0/\<1)[c](#TFN3){ref-type="table-fn"}

ND, not detected;

percent corrected for background Mg^2+^-catalyzed solvolysis;

percent first eluted peak/percent second eluted peak.

###### 

Steady-state kinetic parameters for total product formation from incubation with methylisoborneol synthase.

  Substrate          *k*~cat~ (s^−1^)   *K*~m~ (μM)   *k*~cat~/*K*~m~ (M^−1^s^−1^)
  ------------------ ------------------ ------------- ------------------------------
  2-MeGPP (**3**)    0.105 ± 0.007      95 ± 49       1110
  2-MeNPP (**10**)   0.0046 ± 0.0003    18 ± 6        255
